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DO AID AGENCIES HAVE AN ETHICAL DUTY TO COMPLY WITH 
RESEARCHERS? A RESPONSE TO RENNIE
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RONY ZACHARIAH, VINCENT JANSSENS AND NATHAN FORD
 
ABSTRACT
 
Medical AID organisations such as Médecins Sans Frontières
receive several requests from individuals and international aca-
demic institutions to conduct research at their implementation sites
in Africa.
Do AID agencies have an ethical duty to comply with research
requests? In this paper we respond to the views and constructed
theories (albeit unfounded) of one such researcher, whose request
to conduct research at one of our sites in the Democratic Republic
of Congo was turned down.
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We were very surprised to read the article titled: ‘Is
it Ethical to Study what Ought Not to Happen’.
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The letter we wrote to Stuart Rennie in late 2004
outlining our reasons for not wanting to participate
in his study was just that – a letter from one individ-
ual to another, brieﬂy outlining an opinion about
their study. We did not expect that this personal
response would be selectively quoted and wilfully
misinterpreted in order to construct a largely base-
less criticism. Nor did we imagine that the contents
of this letter would be exaggerated to the point of
becoming an ethical viewpoint, let alone an interna-
tional organisational policy. Rather than entering
into a discussion with Médecins sans Frontières
(MSF) on this important issue, Rennie preferred to
construct a theory on what MSF’s ‘vision’ would be
on various issues and than to criticise this ‘supposed
vision’ for the sake of publishing a paper.
We  will leave aside the important question of
rationing, for which we hope the editors of 
 
Develop-
ing World Bioethics
 
  will, sometime in the future,
allow space for a more legitimate and evidence-
based discussion. We will limit ourselves instead to
addressing the two main themes that Rennie’s paper
evoke for us: do aid agencies have an ethical duty to
comply with researchers, and does calling something
an ethical issue make it one?
 
DO AID AGENCIES HAVE AN 
ETHICAL DUTY TO COMPLY WITH 
RESEARCH REQUESTS?
 
Starting from the title of his article: ‘Is it Ethical to
Study what Ought Not to Happen’, Rennie sets up
the argument that MSF single-handedly halted his
research on ethical grounds. We did neither.
MSF did not at any stage question the right of the
University of North Carolina to undertake this
study in Kinshasa or elsewhere, nor the scientiﬁc
interest that it may entail (although admittedly we
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To  clarify or further discuss any of the points raised in this article,
please contact the corrsponding author directly using the contact infor-
mation supplied at the end of this piece.
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did wonder why the department of dental ecology
was undertaking research on HIV in the Democratic
Republic of Congo). Our reservations were entirely
limited to MSF not being interested in participating
in the study.
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 Given that Rennie considers that this
research question is of considerable importance, one
would expect his ﬁrst response to be to ﬁnd another
study site.
We also did not cast any ethical judgement on the
objective of the study. Rennie argues that it is a
matter of ‘simple transitive logic’
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 that if you view
treatment access rationing as unethical then you
view research into rationing as ‘morally corrupt-
ing’.
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  This is pure hyperbole: holding an opinion
against rationing is not the same as ethically object-
ing to research into rationing. Pre-empting this crit-
icism, Rennie states that: ‘One could argue that
MSF-Belgium is merely stating their own opinion
rather than making a general ethical judgment
about treatment access rationing’.
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  His rebuttal?
‘The language of the letter does not easily support
this interpretation’.
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 The language of MSF’s letter
made not a single reference to the word ethics
(except when citing the title of his research proto-
col). Readers can judge the language of the letter for
themselves: for the sake of transparency, we will
make the full text available.
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In fact, the only objections we raised that can,
without spin, be considered to have ethical weight
were with respect to the study design, which lacked
any mechanisms to ensure community beneﬁt and
did not involve national implementing partners.
Rennie did not respond to either of these concerns,
and has selectively omitted these points in his article.
Another baseless claim Rennie makes as a reason
for MSF’s non-involvement in the study is fear of:
‘Damage to MSF Belgium’s public image’
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 and that,
‘any connection between MSF and rationing would
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Even this point is exaggerated. The letter states that we had ‘serious
reservations on this study being conducted at any MSF site’. This is
translated by Rennie as ‘I was forbidden to involve the local branch of
MSF in my study. Not only that: it was stated that no MSF site any-
where in the world could be involved in my study’.
 
4
 
Rennie, 
 
op.cit.
 
 note 2, p. 73.
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send the wrong message to the world — undoubtedly
including MSF’s ﬁnancial contributors’.
 
10
 
 There is
nothing in our letter, or indeed in his article, upon
which this claim can be justiﬁed, and it is certainly
not the case that any of MSF’s operational activities
are deﬁned by concerns about public image.
The question seems to boil down to this: does
MSF have an ethical obligation to comply with the
requests of researchers? We do not believe this to be
the case. Our ﬁrst duty is to deliver medical assis-
tance to people in need. This does not mean we are
against all forms of research, just that we are not
obliged to participate in it.
Perhaps it could be argued that implementing
agencies do have some sort of obligation, when
placed in a unique position, to provide answers to
urgent and important questions, but in this case we
did not believe the research was of the most pressing
importance. Nor are we uniquely placed to provide
the answer: the unfortunate reality is indeed that
universal access to antiretroviral therapy is still a
long way off, and research into rationing can be
undertaken with hundreds of groups in most coun-
tries of the developing world. And, preferably it will
involve local partners who are most acutely affected
by  the problem, rather than international NGOs
whose ﬁrst priority is not research.
 
DOES CALLING SOMETHING AN ETHICAL 
ISSUE MAKE IT ONE?
 
Rennie makes the point that ‘while it is uncertain
that the letter accurately expresses the ethical
position of MSF on treatment access rationing, it
cannot be ruled out either’.
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  This makes for an
extremely fragile foundation upon which to publish
an article that is entirely about MSF’s ethical posi-
tion on rationing. We would like to take issue with
a number of his assumptions.
‘If not all can be saved, then none shall be saved’
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is stated as MSF’s position by the author, putting
forward yet another baseless claim. Rennie elabo-
rates by saying that MSF has ‘a policy of waiting for
new drugs to treat everyone rather than distributing
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available resources’.
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 We  have no such position or
policy. The reality clearly shows that MSF has often
been the ﬁrst to dare to start antiretroviral treatment
in many countries around the globe while other
actors have refused to act.
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We  take further issue with the position ascribed
to us, in a situation where there were not enough
malaria drugs to go round, that: ‘the ethically right
response would be to wait to get more malaria drugs
until all malaria patients can be treated’.
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  We
believe, and stated so in our letter, that the solution
to this dilemma does not lie in spending energy on
conceiving strategies of rationing but rather in doing
whatever one can to make sure that the drug supply
meets the required demand. But this should be done
at the same time as, not instead of, treating as many
people as one can. Whether you are for or against
rationing you still can, and should, act.
Rennie then raises what he calls an ‘uncomfort-
able but undeniable fact’
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 – but also a wrong fact –
that MSF is implementing AIDS treatment ration-
ing. Within MSF’s programmes, the medical and
social criteria applied to determine who needs anti-
retroviral therapy are employed not as rationing cri-
teria but as good medical practice and public health
practice. Medical criteria (clinical staging, CD4
count, and viral load) are employed to ensure that
only people who need to be treated are treated;
social criteria, where they exist in MSF programs,
are used as public health provisions to avoid provid-
ing antiretroviral therapy to patients with a high
probability of non-adherence and in doing so pro-
moting drug resistance.
To  serve his argument, Rennie interchanges
rationing of care, selection of beneﬁciaries, and set-
ting of priorities. For MSF, these are very distinct
concepts, if they are linked at all. Any organisation
working in situations of humanitarian crisis is faced
permanently with the cruel reality of insufﬁcient
means compared to the massive humanitarian
needs. As one can observe from MSF’s operations,
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neither this incapacity to treat all, nor the lack of
guarantee that treatment will be continued on the
longer run, has prevented MSF from providing con-
crete and direct assistance to people in need. The
selection-exercise this implies is done by MSF on a
basis of programmatic criteria of (medical) vulner-
ability of population groups, intrinsic limits of
MSF’s expertise and capacity, and the feasibility of
qualitative action.
Currently, around six million people in the devel-
oping world are in medical need of antiretroviral
treatment. MSF is treating 56,000 patients in 28
countries. Does this mean that everyone who is not
on treatment is the victim of MSF rationing? Rennie
tries to argue this, but it is absurd to do so. It is
certainly not, as Rennie claims, evidence of a ‘new
position’
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 or a ‘volte face’.
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FINAL REMARKS
 
Aid agencies have a duty to provide the best possible
standard of care on the basis of the best available
evidence. They should also constantly question how
they intervene and learn from their actions and
apply those lessons elsewhere. They do not, however,
have a duty – ethical or otherwise – to comply with
research.
We consider rationing as a tactical acceptance of
injustice that aims to respond to imbalances by
offering only limited assistance for a chosen few.
Some may view this as a naive starting point, but
that is what principles aspiring for justice should be
inspired by. MSF believes that a technical approach
to political distortions will only reﬁne injustice.
When people die, a technique that allows discrimi-
nation between who will die fairly or unfairly
doesn’t seem the right answer.
 
Disclaimer
 
The opinions of the authors are theirs alone. They cannot be taken to
represent the opinions of MSF as a whole, nor of the MSF Brussels-
operational centre.
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